Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03188653 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of Cleansers on the Skin
A NA study, sponsored by University of Arizona.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03188653: Clinical Trial NA study, sponsored by University of Arizona.
NCT03188653 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03188653, a NA study, was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One spot will serve as a control and not receive any cleanser. Each spot will be cleansed with the corresponding cleanser for 15 seconds then rinsed off with tap water. Skin barrier will be measured at baseline, immediately after, 30, 60 and 90 minutes after rinse off.
Primary Outcome
Transepidermal water loss (TEWL) will be measured using hand-held, noninvasive skin barrier measuring device (VapoMeter).
Interventions
- OTHER CeraVe® Eczema Soothing Body Wash
- OTHER Cetaphil® RestoraDerm® Eczema Calming Body Wash
- OTHER Dove® Sensitive Skin Body Wash
- OTHER Eucerin® Skin Calming Body Wash
- OTHER Aveeno® Skin Relief Body Wash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-05-31 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
Why NCT03188653 stopped before completion
NCT03188653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which CeraVe® Eczema Soothing Body Wash is the first listed.
NCT03188653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03188653 about?
NCT03188653 is a clinical study titled "Evaluating the Effects of Cleansers on the Skin". This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One ...
What is the current status of trial NCT03188653?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-31. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT03188653?
The interventions under investigation include: CeraVe® Eczema Soothing Body Wash (OTHER), Cetaphil® RestoraDerm® Eczema Calming Body Wash (OTHER), Dove® Sensitive Skin Body Wash (OTHER), Eucerin® Skin Calming Body Wash (OTHER), Aveeno® Skin Relief Body Wash (OTHER).
Who is sponsoring clinical trial NCT03188653?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03188653's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI